| Code | Description | Claims | Beneficiaries | Total Paid |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
1,518 |
903 |
$5K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
879 |
632 |
$3K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
1,189 |
883 |
$1K |
| 87500 |
|
152 |
134 |
$545.99 |
| 87653 |
|
1,060 |
782 |
$529.07 |
| 87641 |
|
152 |
134 |
$508.48 |
| 87640 |
|
1,198 |
901 |
$424.25 |
| 87801 |
Infectious agent detection by nucleic acid; amplified probe, multiple organisms |
1,033 |
740 |
$364.95 |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
996 |
724 |
$315.81 |
| 87486 |
|
1,058 |
779 |
$315.81 |
| 87561 |
|
1,058 |
778 |
$315.81 |
| 87541 |
|
1,058 |
778 |
$315.81 |
| 87581 |
|
1,058 |
778 |
$315.81 |
| 87481 |
|
64 |
57 |
$274.78 |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
15 |
14 |
$107.62 |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
15 |
14 |
$107.62 |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
14 |
13 |
$106.66 |
| 87529 |
|
14 |
13 |
$102.84 |
| 87503 |
|
32 |
27 |
$0.00 |
| 87532 |
|
32 |
27 |
$0.00 |
| 87496 |
|
32 |
27 |
$0.00 |
| 87498 |
|
32 |
27 |
$0.00 |
| 87631 |
|
106 |
105 |
$0.00 |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
124 |
117 |
$0.00 |
| 87634 |
|
32 |
27 |
$0.00 |